Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-12-12
2006-12-12
Landsman, Robert S. (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S975000, C435S007720, C435S007800, C435S007900, C435S008000
Reexamination Certificate
active
07148018
ABSTRACT:
There is provided a method of identifying a PAR cleaving molecule comprising the steps of: (a) providing an immobilized PAR cleavage peptide linked to a reporter molecule; (b) contacting the immobilized PAR cleavage peptide with a PAR cleaving molecule; and (c) detecting release of the reporter molecule.
REFERENCES:
patent: 5605809 (1997-02-01), Komoriya et al.
patent: 518 557 (1992-12-01), None
patent: WO 91/19000 (1991-12-01), None
patent: WO 98/16657 (1997-10-01), None
patent: WO 98/39471 (1998-03-01), None
patent: WO 98/18456 (1998-05-01), None
patent: WO 99/50415 (1999-10-01), None
Altrogge LM, et al. Analytical Biochem. 277(1):33-45, 2000.
Loew D, et al. Biochemistry. 39(35):10812-22, Sep. 5, 2000.
Karp M et al. Biomolecular Engineering 16(1-4):101-104, 1999.
Fox et al., Identification of Potential Activators of Proteinase-Activated Receptor-2, Febs Letts, vol. 417, pp. 267-269, (1997).
Ishihara et al., “Protease-Activated Receptor 3 Is a Second Thrombin Receptor in Humans”, Nature, vol. 386, No. 6624, pp. 502-506 (1997).
Kahn et al., “Gene and Locus Structure and Chromosomal Localization of the Protease-Activated Receptor Gene Family”, J. Biol. Chem., vol. 273, No. 36, pp. 23290-23296 (1998).
Cronan, “Biotination of Proteinsin Vivo. A Post-Translational Modification to Label, Purify, and Study Proteins”, J. Biol. Chem., vol. 265, No. 18, pp. 10327-10333 (1990).
Vu et al., “Molecular Cloning of a Functional Thrombin Receptor Reveals a Novelproteolytic Mechanism of Receptor Activation”, Cell, vol. 64, pp. 1057-1068 (1991).
Altrogge et al., “An Assay for High-Sensitivity Detection of Thrombin Activity and Determination of Proteases Activating or Inactivating Proteease-Activated Receptors”, Anal. Biochem., vol. 277, No. 1, pp. 33-45 (2000).
Böhm et al., “Molecular Cloning, Expression and Potential Functions of the Human Proteinase-Activated Receptor-2”, Biochem. J., vol. 314, pp. 1009-1016 (1996).
Brass et al., “Communication, Structure and Function of the Human Platelet Thrombin Receptor”, J. Biol. Chem., vol. 267, No. 20, pp. 13795-13798 (1992).
Cavanaugh et al., “Reciprocal Modulation of Astrocyte Stellation by Thrombin and Protease Nexin-1”, J. Neurochem., vol. 54, No. 5, pp. 1735-1743 (1990).
Even-Ram et al., “Thrombin Receptor Overexpression in Malignant and Physiological Invasion Processes”, Nature Med., vol. 4, No. 8, pp. 909-914 (1998).
Fox et al., “Identification of Potential Activators of Proteinase-Activated Receptor-2”, FEBS Lett., vol. 417, pp. 267-269 (1997).
Gerszten et al., Specificity of the Thrombin Receptor for Agonist Peptide is Defined by Its Extracellular Surface, Nature, vol. 368, pp. 648-651 (1994).
Grabham et al., “Thrombin Receptor Activation Stimulates Astrocyte Proliferation and Reversal of Stellation by Distinct Pathways: Involvement of Tyrosine Phosphorylation”, J. Neurochem., vol. 64, No. 2, pp. 583-591 (1995).
Gurwitz et al., “Thrombin Modulates and Reverses Neuroblastoma Neurite Outgrowth”, Proc. Natl. Acad. Sci. USA, vol. 85, pp. 3440-3444 (1988).
Hoffman et al., “The Prolonged Presence of Glia-Derived Nexin, An Endogenous Protease Inhibitor, in the Hippocampus After Ischemia-Induced Delayed Neuronal Death”, Neuroscience, vol. 49, No. 2, pp. 397-408 (1992).
Hung et al., “Thrombin-Induced Events in Non-Platelet Cells Are Mediated by the Unique Proteolytic Mechanism Established for the Cloned Platelet Thrombin Receptor”, J. Cell Biol., vol. 116, No. 3, pp. 827-832 (1992).
Ishii et al., “Determinants of Thrombin Receptor Cleavage”, J. Biol. Chem., vol. 270, No. 27, pp. 16435-16440 (1995).
Kahn et al., “A Dual Thrombin Receptor System for Platelet Activation”, Nature, vol. 394, pp. 690-694 (1998).
Kaufmann et al., “Thrombin Receptor Activation Results in Calcium Signaling and Protein Kinase C-Dependent Stimulation of DNA Synthesis in HEp-2g Laryngeal Carcinoma Cells”, Cancer, vol. 80, No. 11, pp. 2068-2074 (1997).
Kaufmann et al., “Functional Thrombin Receptor PAR1 in Primary Cultures of Human Glioblastoma Cells”, NeuroReport, vol. 9, No. 4, pp. 709-712 (1998).
Kaufmann et al, “Proteinase-Activated Receptor-2-Mediated Signaling and Inhibition of DNA Synthesis in Human Pancreatic Cancer Cells”, Int. J. Pancreatol., vol. 24, No. 2, pp. 97-102 (1998).
Kong et al., “Luminal Trypsin May Regulate Enterocytes Through Proteinase-Activated Receptor-2”, Proc. Natl. Acad. Sci. USA, vol. 94, pp. 8884-8889 (1997).
Loret et al., “Differential Phenotypic Expression Induced in Cultured Rat Astroblasts by Acidic Fibroblast Growth Factor, Epidermal Growth Factor, and Thrombin”, J. Biol. Chem., vol. 264, No. 14, pp. 8319-8327 (1989).
Molino et al., “Proteolysis of the Human Platelet and Endothelial Cell Thrombin Receptor by Neutrophil-Derived Cathepsin G”, J. Biol. Chem., vol. 270, No. 19, pp. 11168-11175 (1995).
Molino et al., “Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2”, J. Biol. Chem., vol. 272, No. 7, pp. 4043-4049 (1997).
Molino et al., “Endothelial Cell Thrombin Receptors and PAR-2”, J. Biol. Chem., vol. 272, No. 17, pp. 11133-11141 (1997).
Nelson et al., “Thrombin and Its Inhibitors Regulate Morphological and Biochemical Differentiation of Astrocytes In Vitro”, Dev. Brain Res., vol. 54, pp. 93-104 (1990).
Nierodzik et al., “Protease-Activated Receptor 1 (PAR-1) Is Required and Rate-Limiting for Thrombin-Enhanced Experimental Pulmonary Metastasis”, Blood, vol. 92, No. 10, pp. 3694-3700 (1998).
Nitsch et al., “Short Communication. The Glia-Derived Protease Nexin 1 Persists For Over 1 Year in Rat Brain Areas Selectively Lesioned by Transient Global Ischaemia”, Eur. J. Neurosci., vol. 5, pp. 292-297 (1993).
Nystedt et al., “Molecular Cloning of A Potential Proteinase Activated Receptor”, Proc. Natl. Acad. Sci. USA, vol. 91, pp. 9208-9212 (1994).
Nystedt et al., “The Mouse Proteinase-Activated Receptor-2 cDNA and Gene”, J. Biol. Chem., vol. 270, No. 11, pp. 5950-5955 (1995).
Parry et al., “Cleavage of the Thrombin Receptor: Identification of Potential Activators and Inactivators”, Biochem. J., vol. 320, pp. 335-341 (1996).
Pindon et al., “Thrombin-Induced Reversal of Astrocyte Stellation is Mediated by Activation of Protein Kinase C β-1”, Eur. J. Biochem., vol. 255, pp. 766-774 (1998).
Rasmussen et al., “cDNA Cloning and Expression of a Hamster α- Thrombin Receptor Coupled to Ca2+Mobilization”, FEBS, vol. 288, No. 1,2 pp. 123-128 (1991),
Renesto et al., “Specific Inhibition of Thrombin-Induced Cell Activation by the Neutrophil Proteinases Elastase, Cathepsin G, and Proteinase 3: Evidence for Distinct Cleavage Sites Within the Aminoterminal Domain of the Thrombin Receptor”, Blood, vol. 89, No. 6, pp. 1944-1953 (1997).
Saifeddine et al., “Rat Proteinase-Activated Receptor-2 (PAR-2): cDNA Sequence and Activity of Receptor-Derived Peptides in Gastric and Vascular Tissue”, Br. J. Pharmacol., vol. 118, pp. 521-530 (1996).
Scotti et al., “Re-Expression of Glia-Derived Nexin/Protease Nexin 1 Depends on Mode of Lesion-Induction or Terminal Degeneration: Observations After Excitotoxin or 6-Hydroxydopamine Lesions of Rat Substantia Nigra”, J. Neurosci. Res., vol. 37, pp. 155-168 (1994).
Smirnova et al., “Thrombin and Its Precursor in Human Cerebrospinal Fluid”, Thromb. Haemost., vol. 78, pp. 1473-1479 (1997).
Smith-Swintosky et al, “Protease Nexin-1 and Thrombin Modulate Neuronal Ca2+Homeostasis and Sensitivity to Glucose Deprivation-Induced Injury”, J. Neurosci., vol. 15, No. 8, pp. 5840-5850 (1995).
Suidan et al., “Thrombin Causes Neurite Retraction in Neuronal Cells through Activation of Cell Surface Receptors
Altrogge Ludger
Monard Denis
Landsman Robert S.
Novartis Forschungsstiftung Zweigniederlassung Friedrich Miesche
Paglierani Paul J.
LandOfFree
Protease-activated receptor (par) modulator assays does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protease-activated receptor (par) modulator assays, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protease-activated receptor (par) modulator assays will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3663227